1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6B68F105A235B708285257D880066BCBA
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/B68F105A235B708285257D880066BCBA!OpenDocument
18
19OpenDocument
2035.173.57.84
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Marketing Management Digital Marketing

Document Excerpt: Digital Marketing Excellence: Impact and Performance Measurement Benchmarks

DB Image

ID: MD-439


Features:

14 Info Graphics

21 Data Graphics

350+ Metrics

4 Narratives


Pages/Slides: 4


Published: Pre-2015


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER

To download this excerpt, click
"Download Free Excerpt".

To return to the study abstract to purchase the full study
- click here

This excerpt includes research findings and metrics from document #5336 "Digital Marketing Excellence: Impact and Performance Measurement Benchmarks."

Industries Profiled:
Pharmaceutical; Health Care; Diagnostic; Manufacturing; Biotech; Consumer Products; Medical Device; Biopharmaceutical; Clinical Research; Laboratories; Marketing


Companies Profiled:
Teva Pharmaceutical Industries Ltd; Abbott; Abbvie; Merck; Bayer; Sanofi; Pfizer; Takeda Pharmaceuticals; Boehringer Ingelheim; Roche; Amgen; GlaxoSmithKline ; Novo Nordisk; Covidien; LEO Pharma; Biogen Idec; Olympus Corporation; Eisai; Mylan; UCB Pharma; Ferring Pharmaceuticals; Lundbeck; Catalent Pharma Solutions; Astellas; CSL Behring; Ranbaxy; Galderma; Chiesi; Boston Scientific; Edwards Lifesciences; Purdue Pharma; Nektar Therapeutics; Merial; Triplefin; biokit; Precision Therapeutics; Genomic Health; Meridian Bioscience; Vivus; Cochlear; Haemonetics Corporation; MD Outlook

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.